FDA Inspection
Charles River Laboratories Cell Solutions IncCharles River Laboratories Cell Solutions Inc – FDA Inspection, Oct 14, 2022
Record Details
This FDA Inspection record concerns Charles River Laboratories Cell Solutions Inc, with an inspection on October 14, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- October 14, 2022
- Product Type
- Biologics
View Company Profile
ID · 3e11f3dc-1ce5-4c35-9c9f-1510512d2367
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1181724
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Charles River Laboratories Cell Solutions Inc
6| Date | Classification | Office | Project area |
|---|---|---|---|
| August 19, 2026 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 4, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 24, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 3, 2013 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 8, 2011 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Charles River Laboratories Cell Solutions Inc
- FDA Inspection 1332852 - 2026-08-19
- FDA Inspection 1056303 - 2018-05-04
- FDA Inspection 988319 - 2016-08-24
- FDA Inspection 847748 - 2013-09-03
- FDA Inspection 743487 - 2011-09-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.